BeiGene, Ltd. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BeiGene, Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q4 2024.
  • BeiGene, Ltd. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$152M, a 58.7% increase year-over-year.
  • BeiGene, Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$645M, a 26.9% increase year-over-year.
  • BeiGene, Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was -$645M, a 26.9% increase from 2023.
  • BeiGene, Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$882M, a 56% increase from 2022.
  • BeiGene, Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$2B, a 37.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$645M -$152M +$216M +58.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$860M -$121M -$337M -156% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$524M -$120M +$261M +68.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$784M -$251M +$97.3M +27.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$882M -$368M +$77.8M +17.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$959M $215M +$773M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$1.73B -$381M +$185M +32.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$1.92B -$348M +$86.8M +19.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$2B -$445M +$161M +26.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$2.16B -$558M -$119M -27.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$2.04B -$566M -$85.4M -17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$1.96B -$435M -$502M -754% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$1.46B -$606M -$133M -28.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$1.32B -$438M -$12.9M -3.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.31B -$480M -$145M -43.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$1.17B $66.5M +$430M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$1.6B -$473M -$84.7M -21.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$1.51B -$425M -$118M -38.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.39B -$335M -$250M -292% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$1.14B -$364M -$196M -117% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$949M -$388M -$120M -44.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$829M -$307M -$163M -113% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$665M -$85.6M +$71.3M +45.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$737M -$168M -$63M -60.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$674M -$268M -$169M -170% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$505M -$144M -$261M -223% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$243M -$157M -$96.3M -159% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$147M -$105M -$54M -107% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$93.1M -$99.3M -$61.7M -164% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$31.4M $117M +$153M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$184M -$60.5M -$36.4M -151% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$148M -$50.6M -$28.6M -130% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$119M -$37.6M -$10.3M -38% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 -$109M -$35.5M -$21.5M -154% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 -$87.4M -$24.1M -$18.5M -328% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 -$68.9M -$22M -$11.8M -115% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 -$57.1M -$27.3M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$14M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-22
Q2 2015 -$5.64M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-22
Q1 2015 -$10.2M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.